Post Profile

Immunotherapy drug a 'gamechanger' for head and neck cancer

Nivolumab found to extend lives of relapsed patients who had run out of therapy options An immunotherapy drug hailed as a potential “gamechanger” in the treatment of cancer could soon offer new hope to patients with currently untreatable forms of the disease. Nivolumab was found to extend the lives of relapsed patients diagnosed with head and neck cancers who had run out of therapy options.
read more


Related Posts

New Cancer Immunotherapy Drugs Linked to Arthritis in Some Patients

Health : Newswise Medical News

Case reports on 13 cancer patients suggest that a small number of cancer patients taking the immunotherapy drugs ipilimumab and nivolumab may be at some higher-than-normal risk of developing autoimmune joint and tissue diseases, inc...

Immunotherapy Drug Improves Survival for Common Form of Lung Cancer

Health : Newswise Medical News

In a head-to-head clinical trial comparing standard chemotherapy with the immunotherapy drug nivolumab, researchers found that people with squamous-non-small cell lung cancer who received nivolumab lived, on average, 3.2 months long...

Nivolumab reduces symptoms in relapsed metastatic head and neck cancer

Health : EurekAlert: Health

(European Society for Medical Oncology) Nivolumab maintains function and reduces symptoms in treatment of relapsed metastatic head and neck cancer, according to results from the CheckMate 141 trial presented at the ESMO 2016 Congres...

Nivolumab Extends Survival for Patients with Advanced Kidney Cancer Treated Beyond Disease Progression

Health : Newswise Medical News

In a large randomized study, the immunotherapy drug nivolumab, a checkpoint inhibitor, was shown to be a safe and effective therapy for kidney cancer even in patients who continued treatment after their disease progressed.

'Game-changing' immunotherapy doubles head and neck cancer survival

Health : EurekAlert: Health

(Institute of Cancer Research) An immunotherapy drug has been hailed as a potential 'game changer' after being found to greatly improve survival for patients with relapsed head and neck cancer -- a disease which is notoriously diffi...


Copyright © 2016 Regator, LLC